Dr. Linda Liau said “…it is feasible to have this vaccine manufactured at 94 centers.”
Yes, that is what she said but I believe she misspoke. I believe she was talking about it being feasible to take the tumor from patients at those 94 sites and sending it off for processing i.e leukapheresis, manufacturing it at the sites we know about (Cognate, UCLA, London, Germany?). Just doing chain of custody is impressive.
Market Data 
Markets 
AI
